Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Report: FDA struggles to track foreign drug trials
Yahoo/AP
Wednesday, June 23, 2010 - 8:08am
tags:
FDA, clinical trials
Affymax: Long-Term Value Far From Anemic
Seeking Alpha
Tuesday, June 22, 2010 - 2:52pm
tags:
Affymax
J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case
BNET Pharma
Tuesday, June 22, 2010 - 2:49pm
tags:
anemia, JNJ, Procrit, Ortho Biotech
Hospira says FDA clears its generic version of AstraZeneca's IV antibiotic Merrem
Yahoo/AP
Tuesday, June 22, 2010 - 2:47pm
tags:
Hospira, FDA, generics, AstraZeneca, Merrem
Biovail-Valeant combo to claim up to 870 jobs
Fierce Pharma
Tuesday, June 22, 2010 - 2:45pm
tags:
Valeant Pharmaceuticals, M&A, layoffs, Biovail
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
BNET Pharma
Tuesday, June 22, 2010 - 12:31pm
tags:
Amgen, Hematide, anemia, Affymax, Takeda
Seattle Genetics' Dark Horse Drug Candidate
Motley Fool
Tuesday, June 22, 2010 - 12:30pm
tags:
Seattle Genetics, cancer, lintuzumab, acute myeloid leukemia
Lilly makes late entry to cholesterol market
Indianapolis Star, IN
Tuesday, June 22, 2010 - 11:23am
tags:
Eli Lilly, cholesterol, Kowa, Livalo
Novo to restart obesity research on Victoza
Fierce Pharma
Tuesday, June 22, 2010 - 11:21am
tags:
Novo Nordisk, Victoza, obesity
Patent Expiry May Open $90 Billion Drug Market for Dr. Reddy’s
Bloomberg
Tuesday, June 22, 2010 - 10:36am
tags:
patents, India, Dr Reddy's, generics, Eli Lilly, Zyprexa
There Is Life After Death, At Least In Biotech
Investopedia
Tuesday, June 22, 2010 - 10:35am
tags:
biotech, Celgene, Genzyme, Gilead Sciences, Isis Pharmaceuticals, Vivus, Neurocrine, Nektar
J&J cuts 2 deals for diabetes treatment
Yahoo/AP
Tuesday, June 22, 2010 - 10:33am
tags:
JNJ, diabetes, Diamyd Medical, partnerships, Metabolex
What's Ailing Teva?
Yahoo/IndieResearch
Tuesday, June 22, 2010 - 9:48am
tags:
Teva Pharmaceuticals, Pfizer
J&J Pays $45M for Diabetes Treatment
TheStreet.com
Tuesday, June 22, 2010 - 9:47am
tags:
JNJ, diabetes, Diamyd Medical, partnerships
Vultures Circling Botox Maker Accused of Hiding Deaths From FDA
BNET Pharma
Tuesday, June 22, 2010 - 9:08am
tags:
Botox, Allergan, FDA
Cadence Pharmaceuticals signs option deal to buy Incline Therapeutics
Yahoo/AP
Tuesday, June 22, 2010 - 9:05am
tags:
Cadence Pharmaceuticals, M&A, Incline Therapeutics
Celator deal with Cephalon expanded
Bizjournals.com
Tuesday, June 22, 2010 - 9:04am
tags:
R&D, partnerships, Cephalon, Celator
J&J Loses Bid To Dismiss Whistleblower Lawsuit
Pharmalot
Tuesday, June 22, 2010 - 9:02am
tags:
JNJ, whistleblowers, lawsuits, kickbacks, Ortho-McNeil
Sanofi May Pay Regulus Up to $750 Million in Deal
Bloomberg
Tuesday, June 22, 2010 - 9:00am
tags:
Sanofi, Regulus, drug development, Isis Pharmaceuticals, Alnylam, fibrosis
Will China Nix the WuXi PharmaTech / Charles River Deal?
Seeking Alpha
Tuesday, June 22, 2010 - 8:58am
tags:
China, M&A, Charles River Laboratories, WuXi PharmaTech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.